The first world wide licensing of Botox ®, as the very first preventative treatments to obtain a specific license for patients with chronic migraine. Allergan had made the announcement that Botox ® was issued a license by MHRA in the United Kingdom for treating headaches in adult patients who have chronic migraines at a …